Spectral cytometry analysis revealed an enrichment of NK and CD8+ T cells and a reduction of Tregs within the total CD45+ tumor immune infiltrate in the OSU13-treated mice (Figure 5, D and E). The gene discussed is PTPRC; the disease is neoplasm.